GovBidAlerts
← All opportunities
This notice has been superseded. See the latest notice: Olopatadine HCL 0.1% Ophthalmic Solution (Award Notice)

Olopatadine HCL 0.1% Ophthalmic Solution

Key dates

Posted
Jan 26, 2024
Response deadline
—
Archive date
Feb 15, 2028
Archive type
autocustom

Classification

Notice type
Award Notice
Base type
Award Notice
Set-aside
—
Set-aside code
—
PSC
6505

NAICS

  • 325412Pharmaceutical Preparation Manufacturing

    This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions. Cross-References. Establishments primarily engaged in--

Issuing office

Department
DEPT OF DEFENSE
Sub-tier
DEFENSE LOGISTICS AGENCY
Office
DLA TROOP SUPPORT
Office code
—
Organization type
OFFICE
Office address
PHILADELPHIA, PA, 19111, USA

Place of performance

Street
—
Street 2
—
City
Ontario
State
Canada
Zip
—
Country
CAN

Contacts

Description

Modification SPE2D223D0007 P00004 to exercise Option Year 1 effective February 15, 2024 through February 14, 2025. Modification SPE2D223D0007 P00003 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract. Modification SPE2D223D0007 P00002 to incorporate clause FAR 52.204-27 Prohibition on a ByteDance Covered Application (JUN 2023) into subject contract. Modification P00001 SPE2D2-23-D-0007 revising the the price effective date and ship date from April 16, 2023 to February 28, 2023. Contract Award for Olopatadine HCL 0.1% Opthtalmic Solution 5ML Bottle

Award

Number
SPE2D223D0007
Amount
$17,621,453.20
Date
Feb 15, 2023
Awardee
GOLDEN STATE MEDICAL SUPPLY INC Camarillo CA 93012 USA
UEI
—
Awardee address
—

Other notices in this solicitation

Similar open contracts

Similar past awards

Metadata

Notice ID
de044b816b9742959497ad68baeb127a
Full path
DEPT OF DEFENSE.DEFENSE LOGISTICS AGENCY.DLA TROOP SUPPORT
Office code
—
Ingested
May 2, 2026
Updated
May 2, 2026
Raw record
{
  "CGAC": "097",
  "City": "PHILADELPHIA",
  "Link": "https://sam.gov/workspace/contract/opp/de044b816b9742959497ad68baeb127a/view",
  "Sol#": "SPE2D222R0117",
  "Type": "Award Notice",
  "State": "PA",
  "Title": "Olopatadine HCL 0.1% Ophthalmic Solution",
  "Active": "Yes",
  "Award$": "17621453.20",
  "Office": "DLA TROOP SUPPORT",
  "PopZip": "",
  "Awardee": "GOLDEN STATE MEDICAL SUPPLY INC Camarillo CA 93012 USA",
  "PopCity": "Ontario",
  "ZipCode": "19111",
  "AAC Code": "SPE2D2",
  "BaseType": "Award Notice",
  "NoticeId": "de044b816b9742959497ad68baeb127a",
  "PopState": "Canada",
  "SetASide": "",
  "Sub-Tier": "DEFENSE LOGISTICS AGENCY",
  "AwardDate": "2023-02-15",
  "FPDS Code": "97AS",
  "NaicsCode": "325412",
  "PopCountry": "CAN",
  "PostedDate": "2024-01-26 12:08:31.702-05",
  "ArchiveDate": "2028-02-15",
  "ArchiveType": "autocustom",
  "AwardNumber": "SPE2D223D0007",
  "CountryCode": "USA",
  "Description": "Modification SPE2D223D0007 P00004 to exercise Option Year 1 effective February 15, 2024 through February 14, 2025. Modification SPE2D223D0007 P00003 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract. Modification SPE2D223D0007 P00002 to incorporate clause FAR 52.204-27 Prohibition on a ByteDance Covered Application (JUN 2023) into subject contract. Modification P00001 SPE2D2-23-D-0007 revising the the price effective date and ship date from April 16, 2023 to February 28, 2023. Contract Award for Olopatadine HCL 0.1% Opthtalmic Solution 5ML Bottle",
  "SetASideCode": "",
  "OrganizationType": "OFFICE",
  "PopStreetAddress": "",
  "ResponseDeadLine": "",
  "PrimaryContactFax": "",
  "AdditionalInfoLink": "",
  "ClassificationCode": "6505",
  "PrimaryContactEmail": "Phyllis.Daraio@dla.mil",
  "PrimaryContactPhone": "2157377941",
  "PrimaryContactTitle": "",
  "SecondaryContactFax": "",
  "Department/Ind.Agency": "DEPT OF DEFENSE",
  "SecondaryContactEmail": "jason.wray@dla.mil",
  "SecondaryContactPhone": "2157370614",
  "SecondaryContactTitle": "",
  "PrimaryContactFullname": "Phyllis Daraio",
  "SecondaryContactFullname": "Jason Wray"
}